4//SEC Filing
Chen Hongming 4
Accession 0001179110-20-000157
CIK 0001479419other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:12 PM ET
Size
5.3 KB
Accession
0001179110-20-000157
Insider Transaction Report
Form 4
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2020-01-02+120,000→ 120,000 totalExercise: $3.84Exp: 2030-01-01→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 2, 2020 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001710697
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:12 PM ET
- Size
- 5.3 KB